NCT06921382 Breastfeeding Intervention to Prevent Obesity Among Children
| NCT ID | NCT06921382 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of North Carolina, Greensboro |
| Condition | Breastfeeding Self-Efficacy |
| Study Type | INTERVENTIONAL |
| Enrollment | 170 participants |
| Start Date | 2025-03-17 |
| Primary Completion | 2027-06-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 170 participants in total. It began in 2025-03-17 with a primary completion date of 2027-06-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn how to improve exclusive breastfeeding rates. The main questions it aims to answer are: Do Hispanic mothers benefit from peer counseling support from peer counselors who can speak Spanish? Are mothers more likely to continue exclusive breastfeeding if additional funds are given so that the WIC exclusive breastfeeding package has the same cash value as the WIC formula feeding package? Researchers will compare participants in the intervention group (who receive peer counseling and additional funds) to a control group (who do not receive peer counseling or additional funds) to see if the intervention package improves breastfeeding rates. All participants (intervention and control) will complete weekly surveys about their feeding experiences ($8 per week). Members of the research team will also take infant weight/length measurements at home (twice during the first month and then at 2, 4, and 6 months). Participants will be recruited during pregnancy and the study will last for the first 6 months after their babies are born. Mothers and their infants are both participants in the study. Participants in the intervention condition will also be matched with Spanish-speaking peer counselors who will visit mothers at home regularly (weekly at the beginning of the study, monthly at the end of the study). In Month 1, mothers can choose to receive a $150 gift card or an electric breast pump. In Months 2-5, if infants are signed up for the WIC exclusive breastfeeding package, infants will receive $100 and mothers will receive $50. If infants are signed up for the WIC partial breastfeeding package, infants will receive $50 and mothers will receive $30.
Eligibility Criteria
Mothers and infants are both participants in the study. By the time study activities start, infants will be around 5 days old. Inclusion Criteria Set 1 (determined at prenatal recruitment): 1. Confirmation of Hispanic origin 2. Receives or eligible for WIC 3. Mother is 18 years or older 4. Singleton pregnancy 5. Mother intends to breastfeed. Inclusion Criteria Set 2 (determined after infants are born): 1. Infant gestational age 37 weeks or more 2. Normal infant birth weight (i.e., \> 5 lbs 8 oz.) 3. Breastfeeding has been initiated 4. No congenital or other health issues (such as cleft palate) identified that require specific accommodations for feeding. Exclusion Criteria: 1. Mothers below 18 years of age. 2. Mothers do not plan to breastfeed. 3. Mothers not eligible to participate in the WIC program due to high household income 4. Non-singleton pregnancy.
Contact & Investigator
Jasmine M DeJesus, PhD
PRINCIPAL INVESTIGATOR
UNC Greensboro
Frequently Asked Questions
Who can join the NCT06921382 clinical trial?
This trial is open to participants of all sexes, aged 5 Days or older, studying Breastfeeding Self-Efficacy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06921382 currently recruiting?
Yes, NCT06921382 is actively recruiting participants. Contact the research team at jmdejes2@uncg.edu for enrollment information.
Where is the NCT06921382 trial being conducted?
This trial is being conducted at Greensboro, United States, Greensboro, United States.
Who is sponsoring the NCT06921382 clinical trial?
NCT06921382 is sponsored by University of North Carolina, Greensboro. The principal investigator is Jasmine M DeJesus, PhD at UNC Greensboro. The trial plans to enroll 170 participants.